|
Dec 8
|
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
|
|
Dec 8
|
Zacks Market Edge Highlights: SAIC, ANET, LLY, PFE and SIG
|
|
Dec 7
|
Chase Coleman Stock Portfolio: 10 Top Stock Picks
|
|
Dec 7
|
Will There Be a Recession in 2024?
|
|
Dec 7
|
Top 20 Most Valuable American Companies Today
|
|
Dec 7
|
Dow Jones Climbs After Jobless Claims Rise; Google Stock Surges After Gemini AI Model
|
|
Dec 7
|
13 Best S&P 500 Dividend Stocks To Buy
|
|
Dec 7
|
Should You Buy Eli Lilly Stock Now or Wait for a Dip?
|
|
Dec 7
|
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?
|
|
Dec 5
|
Pfizer’s Weight-Loss Pill Disappointment Is an Opening for Biotech Rivals
|
|
Dec 5
|
13 Best Jim Cramer Stocks To Buy Now
|
|
Dec 5
|
Lilly to Present Final Overall Survival Analysis from the MONARCH 3 Study of Verzenio® (abemaciclib) and Additional Results from Its Breast Cancer Portfolio at the 2023 San Antonio Breast Cancer Symposium
|
|
Dec 5
|
Eli Lilly obesity drug now available in US pharmacies
|
|
Dec 5
|
UPDATE 4-Eli Lilly obesity drug now available in US pharmacies
|
|
Dec 5
|
Zepbound™ (tirzepatide) is Now Available in U.S. Pharmacies for Adults Living with Obesity
|
|
Dec 5
|
25 States with the Lowest Life Expectancy in the US
|
|
Dec 4
|
Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From Eli Lilly Deal
|
|
Dec 4
|
Lilly (LLY) Gets Second FDA Nod for Lymphoma Drug Jaypirca
|
|
Dec 4
|
Altimmune (ALT) Rises 83% on Successful Phase II Obesity Study
|
|
Dec 4
|
Roche Strikes $3.1 Billion Deal for Obesity Drugmaker. It’s Hoping to Compete with Eli Lilly, Novo Nordisk.
|